Abeona Therapeutics (ABEO) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$721.6 million.
- Abeona Therapeutics' Retained Earnings rose 1024.69% to -$721.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$721.6 million, marking a year-over-year increase of 1024.69%. This contributed to the annual value of -$813.3 million for FY2024, which is 850.33% down from last year.
- Per Abeona Therapeutics' latest filing, its Retained Earnings stood at -$721.6 million for Q3 2025, which was up 1024.69% from -$716.5 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Retained Earnings ranged from a high of $688.2 million in Q3 2022 and a low of -$825.3 million during Q1 2025
- In the last 5 years, Abeona Therapeutics' Retained Earnings had a median value of -$716.5 million in 2025 and averaged -$640.3 million.
- In the last 5 years, Abeona Therapeutics' Retained Earnings surged by 21301.54% in 2022 and then plummeted by 20649.77% in 2023.
- Abeona Therapeutics' Retained Earnings (Quarter) stood at -$655.6 million in 2021, then fell by 6.05% to -$695.3 million in 2022, then fell by 7.79% to -$749.5 million in 2023, then dropped by 8.5% to -$813.3 million in 2024, then rose by 11.27% to -$721.6 million in 2025.
- Its last three reported values are -$721.6 million in Q3 2025, -$716.5 million for Q2 2025, and -$825.3 million during Q1 2025.